BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 12729320)

  • 1. Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma.
    Nakamoto N; Saito H; Ebinuma H; Tada S; Saito Y; Kurita S; Kitamura K; Ishii H
    Intern Med; 2003 Apr; 42(4):322-30. PubMed ID: 12729320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
    Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
    Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
    Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
    J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.
    Kusakabe A; Tanaka Y; Orito E; Sugauchi F; Kurbanov F; Sakamoto T; Shinkai N; Hirashima N; Hasegawa I; Ohno T; Ueda R; Mizokami M
    J Gastroenterol; 2007 Apr; 42(4):298-305. PubMed ID: 17464459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues.
    Urashima T; Saigo K; Kobayashi S; Imaseki H; Matsubara H; Koide Y; Asano T; Kondo Y; Koike K; Isono K
    J Hepatol; 1997 Apr; 26(4):771-8. PubMed ID: 9126788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of serum HBV DNA and anti-HCV antibody in HBsAg seronegative patients with hepatocellular carcinoma in Japan.
    Tokeshi S; Sata M; Tanikawa K
    Kansenshogaku Zasshi; 1996 Feb; 70(2):103-7. PubMed ID: 8851381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
    Coppola N; Onorato L; Iodice V; Starace M; Minichini C; Farella N; Liorre G; Filippini P; Sagnelli E; de Stefano G
    Oncotarget; 2016 Sep; 7(38):62706-62714. PubMed ID: 27486882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
    Bréchot C; Jaffredo F; Lagorce D; Gerken G; Meyer zum Büschenfelde K; Papakonstontinou A; Hadziyannis S; Romeo R; Colombo M; Rodes J; Bruix J; Williams R; Naoumov N
    J Hepatol; 1998 Aug; 29(2):173-83. PubMed ID: 9722197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection.
    Matsui S; Ichida T; Watanabe M; Sugitani S; Suda T; Takahashi T; Asakura H
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1205-11. PubMed ID: 11106103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues.
    Zhong S; Chan JY; Yeo W; Tam JS; Johnson PJ
    J Viral Hepat; 2000 Mar; 7(2):115-23. PubMed ID: 10760041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
    Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
    J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.
    Matsuzaki Y; Chiba T; Hadama T; Asaoka H; Doy M; Shoda J; Tanaka N; Kinoshita M
    Cancer Lett; 1997 Oct; 119(1):53-61. PubMed ID: 18372522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
    Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
    Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatita B and C virus infections in patients with hepatocellular carcinoma].
    Crespo J; Dueñas C; Sánchez-Antolín G; Fábrega E; Carte B; Pons-Romero F
    Med Clin (Barc); 1996 Feb; 106(7):241-5. PubMed ID: 8667672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepatitis B virus surface antigen: an analysis of two Japanese cases.
    Shiota G; Oyama K; Udagawa A; Nomi T; Tanaka K; Tsutsumi A; Noguchi N; Okano J; Kishimoto Y; Kanbe T; Kishimoto H; Kawasaki H
    Hepatogastroenterology; 2009; 56(94-95):1516-20. PubMed ID: 19950820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.